No results displayed.
Inside "Cancer by Type":
@CancerQuest on Twitter:
Related to this page:
Was this page helpful?
|
Page 4 of 9 | <Previous : Next> Jump to Page:

Leukemia: Risk Factors

Although the cause of leukemia in most patients is unknown, several factors are associated with increased risk of developing the disease. Factors that influence risk of developing leukemia include:

  • Age
  • Prior Chemotherapy
  • Ethnicity/Gender
  • Inherited Syndromes (such as Down Syndrome)
  • Ionizing Radiation
  • Infection by certain viruses
  • Cigarette smoking

The relative effects of these and other risk factors in any given case of cancer is variable. Some of these and other risk factors are discussed on the following pages.

Age
The risk of developing most types of leukemia increases steadily with age. The curve for acute lymphoblastic leukemia (ALL) incidence, however, is U-shaped: highest between the ages of 3-7 and rising again after the age of 40.(1) The reason for this peak in early childhood ALL remains uncertain.

More information about the relationship between cancer and age can be found in the Mutation section.

Chemotherapy
There is a subset of acute myeloid leukemia (AML), known as "secondary AML" or "therapy-related myeloid leukemia," which can develop following treatment with chemotherapy. Although a causal relationship is implied by the name, the exact mechanism remains unknown.(2)Prognosis for secondary AML is generally unfavorable compared to primary AML.(3)

Ethnicity/Gender
With the exception of chronic myeloid leukemia (CML), which has a similar incidence in whites and blacks, leukemia occurs more commonly in those of white ancestry compared to those of Asian, Hispanic and black ancestry. Leukemia also occurs more frequently in males than females.(1)

Inherited Syndromes
Children with Down syndrome (DS) have a roughly 20-fold increased risk of developing childhood leukemia compared to children without DS.(4)Approximately 10% of children with DS are born with a "transient leukemia" that resolves spontaneously within months of birth. One to two percent, however, develop a malignant acute leukemia requiring chemotherapy by the age of 4.(5) While several hypotheses have been proposed, the reason for this increased risk remains uncertain.

Other inherited syndromes that increase risk of leukemia include:

  • Ataxia-telangiectasia(6)
  • Bloom syndrome
  • Fanconi syndrome(7)
  • Klinefelter syndrome(8)
  • Neurofibromatosis

Ionizing Radiation
An increase in leukemia has been observed in survivors of the atomic bombing of Japanese cities. Although the risk associated with exposure to lower level radiation is not clear, studies have shown an increase in leukemia following the use of radiotherapy for ankylosing spondylitis (a form of arthritis) and exposure to diagnostic X-rays of the fetus during pregnancy.(9)

Viruses
Infection with Human T-cell Lymphotropic Virus-1 (HTLV-I) is linked to the development of Adult T-cell Leukemia/Lymphoma (ATLL), a cancer of activated mature T lymphocytes.(10) Learn more about T lymphocytes

HTLV-I and ATLL are widespread in certain regions of the world, such as the Caribbean basin, Japan, and parts of South America and Africa, while very rare in others.(10) Most people who are infected with HTLV-I do not develop leukemia.(11) Data from cancer registries in Japan suggest the lifetime risk of developing ATLL among those infected is 2.1% for females and 6.6% for males.(12)

Although the exact mechanism by which HTLV-I infection induces cancer is not known, laboratory studies have identified several mechanisms which may be involved. (12) Learn more about viruses and cancer

Page 4 of 9 | <Previous : Next>
Last Modified: 10/03/2011 Print Email Page Share
References for this page:
  1. Yamamoto JF, Goodman MT. "Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002." Cancer Causes Control. 2007 Dec 7 [Epub ahead of print] [PUBMED]
  2. Larson RA, "Etiology and management of therapy-related myeloid leukemia." Hematology Am Soc Hematol Educ Program. 2007;2007:453-9. [PUBMED]
  3. Hoffbrand AV, Moss PAH, Pettit JE (ed). "Essential Haematology" 5th Edition. Blackwell Publishing, Oxford: 2006. Pg. 167.
  4. Alderton LE, Spector LG, Blair CK, Roesler M, Olshan AF, Robison LL, Ross JA. "Child and maternal household chemical exposure and the risk of acute leukemia in children with Down's syndrome: a report from the Children's Oncology Group." Am J Epidemiol. 2006 Aug 1;164(3):212-21. Epub 2006 Jun 7. [PUBMED]
  5. Izraeli S, Rainis L, Hertzberg L, Smooha G, Yehudit B. "Trisomy of chromosome 21 in leukemogenesis." Blood Cells Mol Dis. 2007 Sep-Oct;39(2):156-9. Epub 2007 May 29. [PUBMED]
  6. Armata HL, Garlick DS, Sluss HK. "The ataxia telangiectasia-mutated target site ser18 is required for p53-mediated tumor suppression." Cancer Res. 2007 Dec 15;67(24):11696-703. [PUBMED]
  7. Meyer S, Fergusson WD, Whetton AD, Moreira-Leite F, Pepper SD, Miller C, Saunders EK, White DJ, Will AM, Eden T, Ikeda H, Ullmann R, Tuerkmen S, Gerlach A, Klopocki E, Tonnies H. "Amplification and translocation of 3q26 with overexpression of EVII in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCDI/BRCA2 disruption." Genes Chromosomes Cancer. 2007 Apr;46(4):359-72. [PUBMED]
  8. Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA. "Cancer incidence and mortality in men with klinefelter syndrome: a cohort study." J Natl Cancer Inst. 2005 Aug 17;97(16):1204-10. [PUBMED]
  9. Boon et al. "Principles & Practice of Medicine." (20th edition) Churchill Livingstone, 2006. Pgs 1039-1047.
  10. Matutes E. "Adult T-cell leukaemia/lymphoma." J Clin Pathol. 2007 Dec;60(12):1373-7. [PUBMED]
  11. Hoffbrand AV, Moss PAH, Pettit JE (ed). "Essential Haematology" 5th Edition. Blackwell Publishing, Oxford: 2006. Pg. 195.
  12. Taylor G. "Molecular aspects of HTLV-1 infection and adult T-cell leukaemia/lymphoma." J Clin Pathol. 2007 Dec;60(12):1392-6. [PUBMED]
Copyright ©2012 Emory University. All rights reserved.
Direct questions and comments to cancerquest@emory.edu.
Disclaimer | Legal Policies | Contact
Follow @CancerQuest on Twitter
CancerQuest Dictionary
Follow us on: